The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
Open accessAbstract
BACKGROUND: Human papillomavirus (HPV) infection, particularly with type 16, causes a growing fraction of oropharyngeal cancers, whose incidence is increasing, mainly in developed countries. In a double-blind controlled trial conducted to investigate vaccine efficacy (VE) of the bivalent HPV 16/18 vaccine against cervical infections and lesions, we estimated VE against prevalent oral HPV infections 4 years after vaccination. METHODS AND FINDINGS: A total of 7,466 women 18-25 years old were randomized (1∶1) to receive the HPV16/18 vaccine or hepatitis A vaccine as control. At the final blinded 4-year study visit, 5,840 participants provided oral specimens (91·9% of eligible women) to evaluate VE against oral infections. Our primary analysis evaluated prevalent oral HPV infection among all vaccinated women with oral and cervical HPV results. Corresponding VE against prevalent cervical HPV16/18 infection was calculated for comparison. Oral prevalence of identifiable mucosal HPV was relatively low (1·7%). Approximately four years after vaccination, there were 15 prevalent HPV16/18 infections in the control group and one in the vaccine group, for an estimated VE of 93·3% (95% CI = 63% to 100%). Corresponding efficacy against prevalent cervical HPV16/18 infection for the same cohort at the same visit was 72·0% (95% CI = 63% to 79%) (p versus oral VE = 0·04). There was no statistically significant protection against other oral HPV infections, though power was limited for these analyses. CONCLUSIONS: HPV prevalence four years after vaccination with the ASO4-adjuvanted HPV16/18 vaccine was much lower among women in the vaccine arm compared to the control arm, suggesting that the vaccine affords strong protection against oral HPV16/18 infection, with potentially important implications for prevention of increasingly common HPV-associated oropharyngeal cancer. ClinicalTrials.gov, Registry number NCT00128661.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Agresti, A. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/0471249688 · Cited by 6,746
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Herrero, R. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg107 · Cited by 1,228
Self-citationEfficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Giuliano, A. R., Palefsky, J. M., Goldstone, S., Moreira, E. D., Penny, M. E., Aranda, C., Vardas, E., Moi, H., Jessen, H., Hillman, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0909537 · Cited by 1,146
Prevalence of Oral HPV Infection in the United States, 2009-2010
Gillison, M. L., Broutian, T., Pickard, R. K. L., Tong, Z.-Y., Xiao, W., Kahle, L., Graubard, B. I., & Chaturvedi, A. K. (2012) · JAMA · doi:10.1001/jama.2012.101 · Cited by 1,064
Epidemiologic Analysis with a Programmable Calculator
Rothman, K. J., Boice, H. D., & Austin, H. D. (1982) · American Journal of Epidemiology · Cited by 1,039
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
Palefsky, J. M., Giuliano, A. R., Goldstone, S., Moreira, E. D., Aranda, C., Jessen, H., Hillman, R., Ferris, D., Coutlee, F., Stoler, M. H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010971 · Cited by 948
Näsman, A., Attner, P., Hammarstedt, L., Du, J., Eriksson, M., Giraud, G., Ährlund‐Richter, S., Marklund, L., Romanitan, M., Lindquist, D., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24339 · Cited by 720
Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., Skinner, S. R., Apter, D., Naud, P., Salmerón, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70286-8 · Cited by 704
Carcinogenicity of human papillomaviruses
Cogliano, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., & Ghissassi, F. E. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70086-3 · Cited by 688
Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T., Gonzalez, P., Dubin, G., Porras, C., et al. (2007) · JAMA · doi:10.1001/jama.298.7.743 · Cited by 666
Self-citationKleter, B., van Doorn, L.-J., Schrauwen, L., Molijn, A., Sastrowijoto, S., ter Schegget, J., Lindeman, J., ter Harmsel, B., Burger, M., & Quint, W. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.8.2508-2517.1999 · Cited by 655
Self-citationMuñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp534 · Cited by 566
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women
Gillison, M. L., Chaturvedi, A. K., & Lowy, D. R. (2008) · Cancer · doi:10.1002/cncr.23764 · Cited by 517
Self-citationKleter, B., van Doorn, L.-J., ter Schegget, J., Schrauwen, L., van Krimpen, K., Burger, M., ter Harmsel, B., & Quint, W. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65688-x · Cited by 509
Self-citationOral Human Papillomavirus in Healthy Individuals: A Systematic Review of the Literature
Kreimer, A. R., Bhatia, R. K., Messeguer, A. L., González, P., Herrero, R., & Giuliano, A. R. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181c94a3b · Cited by 312
Self-citationCollection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash.
García‐Closas, M., Egan, K. M., Abruzzo, J., Newcomb, P. A., Titus-Ernstoff, L. T., Franklin, T., Bender, P. K., Beck, J. C., Marchand, L. L., Lum, A., et al. (2001) · PubMed · Cited by 285
Barr, E., & Koutsky, L. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh071 · Cited by 230
Nardelli-Haefliger, D., Wirthner, D., Schiller, J. T., Lowy, D. R., Hildesheim, A., Ponci, F., & De Grandi, P. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg018 · Cited by 207
Self-citationKreimer, A. R., González, P., Katki, H. A., Porras, C., Schiffman, M., Rodriguez, A. C., Solomon, D., Jiménez, S., Schiller, J. T., Lowy, D. R., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70213-3 · Cited by 194
Self-citationDessy, F. J., Giannini, S. L., Bougelet, C. A., Kemp, T. J., David, M.-P. M., Poncelet, S. M., Pinto, L. A., & Wettendorff, M. A. (2008) · Human Vaccines · doi:10.4161/hv.4.6.6912 · Cited by 179
Herrero, R., Wacholder, S., Rodríguez, A. C., Solomon, D., González, P., Kreimer, A. R., Porras, C., Schussler, J., Jiménez, S., Sherman, M. E., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0131 · Cited by 177
Self-citationHerrero, R., Hildesheim, A., Rodríguez, A. C., Wacholder, S., Bratti, C., Solomon, D., González, P., Porras, C., Jiménez, S., Guillen, D., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.002 · Cited by 169
Self-citationvan Doorn, L.-J., Molijn, A., Kleter, B., Quint, W., & Colau, B. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00539-06 · Cited by 163
Self-citationAntibody Responses in Oral Fluid after Administration of Prophylactic Human Papillomavirus Vaccines
Rowhani‐Rahbar, A., Carter, J. J., Hawes, S. E., Hughes, J. P., Weiss, N. S., Galloway, D. A., & Koutsky, L. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/606026 · Cited by 39
Cited by
Head and neck squamous cell carcinoma
Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00224-3 · Cited by 4,067
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
Gillison, M. L., Chaturvedi, A. K., Anderson, W. F., & Fakhry, C. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6995 · Cited by 1,219
Oral cavity and oropharyngeal squamous cell carcinoma—an update
Chi, A. C., Day, T. A., & Neville, B. W. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21293 · Cited by 1,094
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management
Lechner, M., Liu, J., Masterson, L., & Fenton, T. R. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00603-7 · Cited by 979
The changing therapeutic landscape of head and neck cancer
Cramer, J. D., Burtness, B., Le, Q. T., & Ferris, R. L. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0227-z · Cited by 783
Metadata
- Authors
- Herrero, R., Quint, W., Hildesheim, A., Gonzalez, P., Struijk, L., Katki, H. A., Porras, C., Schiffman, M., Rodriguez, A. C., Solomon, D., Jimenez, S., Schiller, J. T., Lowy, D. R., van Doorn, L.-J., Wacholder, S., Kreimer, A. R., & for the CVT Vaccine Group
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-17
- Volume
- 8
- Issue
- 7
- Pages
- e68329
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2113000896
- Cited by
- 473
- References
- 27
- FWCI
- 38.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.